NEDD9 and breast carcinoma: We used breast carcinoma MCF7 cells to overexpress (Figure 1A) or siRNA-deplete (Figure 1B) BCAR1 and NEDD9, individually or in combination, and monitored total expression of E-cadherin and its partner proteins α-, β-, and p120catenin.